Melanie B. Thomas

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Edgar Ben‐Josef, Katherine A. Guthrie, Anthony B. El-Khoueiry et al. · Journal of Clinical Oncology · 2015 · 409 citations

Medicine, Oncology, Surgery +17

Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting

Melanie B. Thomas, Deborah Jaffe, Michael M. Choti et al. · Journal of Clinical Oncology · 2010 · 394 citations

Medicine, Oncology, Cancer Control +16

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases

Dario Ribero, Huamin Wang, Matteo Donadon et al. · Cancer · 2007 · 376 citations · Full text

Medicine, Oncology, Pharmacology +13

Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma

Melanie B. Thomas, Jeffrey S. Morris, Romil Chadha et al. · Journal of Clinical Oncology · 2009 · 335 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma

Melanie B. Thomas, Romil Chadha, Katrina Y. Glover et al. · Cancer · 2007 · 306 citations

Medicine, Oncology, Pharmacology +17